NCT02171715View on ClinicalTrials.gov

BIBW 2992 Administered as Tablet (Final Formulation) Compared to BIBW 2992 Drinking Solution and BIBW 2992 Tablet (Trial Formulation II) in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

April 30, 2009

Conditions
Healthy
Interventions
DRUG

BIBW 2992 MA2

film-coated immediate release tablet - final formulation

DRUG

BIBW 2992 MA2

film-coated immediate release tablet - trial formulation II

DRUG

BIBW 2992 MA2

powder for oral solution

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY